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A BST R AC T   
 
Aim: The best treatment for patient with end stage kidney disease is kidney transplantation which 
improve their quality of life and survival rate. The aim of our study is to determine the factors that 
affect the results of early outcomes of graft function.  
Method: Twenty-eight adult patients who underwent renal transplantation from 2016 to 2017 were 
included in our university.  
Results: The median age of the recipients was 38.5 (range: 19-65) and 68% (19 patients) were male. 
Acute rejection was detected in 8 patients. Patients who developed rejection were found to have 
higher panel reactive antibody positivity and higher parathyroid hormone levels. Panel reactive 
antibody positivity was found to be 25% in patients who developed rejection and 0% in patients who 
did not develop rejection (p = 0.02). The parathyroid hormone level was calculated as 963.2 ± 587 in 
the rejection group and 378 ± 227 in the rejection group (p = 0.003). It was observed that 37.5% of 
DM patients had rejection and 10% in non-diabetic patients. The difference was statistically 
significant (p = 0.08). 
Conclusion: Panel reactive antibody positivity and parathyroid hormone levels increased the 
likelihood of rejection. The effect of the presence of diabetes mellitus in the patient on the 
development of rejection was observed to be limited. Our findings were consistent with the literature. 
Because of the number of patients and the short follow-up period, further studies are needed. 
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Introduction 
Renal transplantation has been preferred for 
better survival and quality of life in patients 
with end-stage renal diseases [1]. Studies have 
shown that many donor and recipient factors 
affect patient survival after transplantation. 
Some of these factors include age, gender, body 
weight, number of human leukocyte antigen 
(HLA) mismatches, duration of warm ischemia, 
development of acute rejection, delayed graft 
function, general health status, proteinuria, 
albumin level, Panel Reactive Antibody (PRA), 
new onset hypertension (HT), diabetes mellitus 
(DM), hyperlipidemia, cytomegalovirus, 
hepatitis B, hepatitis C infections, serum uric 
acid level, gene polymorphisms (Caveolin 1, 
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chemokine receptor 5 polymorphism, etc.) and 
serum homocysteine levels [2-10]. 
Studies on early graft survival after renal 
transplantation are important in terms of 
contributing to long-term outcomes. Pre-
transplant blood product transfusion history 
may result in HLA antigen sensitization. The 
highest risk for sensitization occurred in 
multipara women, multiple transfusions and 
failed organ transplants. Frequent transfusion 
also caused an increase in PRA. The pro-
inflammatory condition adversely affects graft 
survival [11,12]. 
In the preoperative era, imaging of renal 
vascular system is important for surgical 
success and graft survival. Transplantation 
using multiple renal artery grafts is as safe as 
single-artery grafts when evaluated for urologic 
complications [13]. Another factor related to 
the survival of the transplanted kidney is the age 
of the recipient and donor. Renal recipients over 
60 years of age have an increased risk of graft 
failure [14]. Graft failure and long-term 
mortality have also increased in recipients of 
older donors compared to younger kidney 
donation cases [15]. The incidence of early 
graft failure in obese recipients is probably 
increased because of vascular suture problems 
[16,17]. Previous or active smoking is 
associated with decreased patient and graft 
survival and increased rejection rate [18]. 
Although diabetes is a common cause of end-
stage renal disease, new-onset diabetes mellitus 
after transplantation can be an important 
complication of renal transplantation via 
affecting the survival of allograft by increasing 
cardiovascular risk [19-22]. Low post-dialysis 
systolic blood pressure and low pre-dialysis 
diastolic blood pressure were associated with 
decreased risk of death, whereas post-dialysis 
high diastolic blood pressure was associated 
with increased risk of death. Low blood 
pressure before transplantation was also 
associated with decreased risk of graft failure 
[23]. Ischemia reperfusion injury after renal 
transplantation affects short-term and long-term 
graft outcomes. Ischemia reperfusion injury is 
associated with delayed graft function, graft 
rejection, chronic rejection and chronic graft 
dysfunction [24]. 
Studies based on protocol biopsies have shown 
that acute rejection of both cellular and humoral 
type may lead to long-term changes due to 
reduced graft survival [25-28]. Compared with 
patients without acute rejection, those with 
acute rejection in the first year were observed 
more frequently in patients with HLA 
mismatches [29]. Decreased early graft 
function after kidney donation from live donors 
was found to reduce graft survival without 
rejection. However, the effect on graft survival 
in the long term is uncertain [30]. Therefore, we 
conducted a retrospective study to show the 
factors affecting early graft survival after renal 
transplantation in our institution. 
 
Materials and Methods 
The study was enrolled 28 sequential adult 
cases who underwent kidney transplantation 
from the living donor between 2016 and 2017 
at transplantation clinic of our University 
Hospital. We also enrolled data of 28 donors. 
The study was designed retrospectively. The 
study was conducted in accordance with the 
ethical approval of the University Ethics 
Committee (Decision number: 29032017-4). 
The data were obtained from the hospital 
database and patients’ files. Age, gender, 
additional diseases, weight, height and 
laboratory test results were recorded.  
For the statistical analyzes, IBM SPSS 
(Statistical Package for the Social Sciences) 
Version 16.0 software was used. In the study, 
numerical data are given as median (range). 
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Categorical and non-parametric variables were 
analyzed with Chi-square test and Mann 
Whitney U test, respectively. Statistical first 
type error margin (α) was taken as 0.05 for this 
study. Therefore, the results for p <α were 
considered statistically significant at 95% 
confidence level. 
 
Results  
The median age of the recipients was 38.5 
(range: 19-65) years and 68% of the subjects 
(19 patients) were male. Fifty percent (14 
patients) had a history of cigarette smoking. 
The median body mass index of the patients 
was 23 (range: 16-34) kg/m2. Hypertension and 
diabetes mellitus were in 46% and 18% of the 
patients. Glomerulonephritis was the etiologic 
factor of end stage renal disease in the 
remaining subjects. When ABO blood groups 
were examined, it was observed that 54% have 
A, 21% have B, and 25% have 0 group type. 
Besides, 89% of the patients were Rh + and 
remaining were Rh-. 
Median creatinine and GFR values of graft 
kidneys at 0, 3 and 6 months were given in 
Table 1.  
 
Table 1. The creatinine and GFR values of the 
grafts at 0, 3 and 6 months after transplantation. 
 
 
 
 
 
 
 
The median age of the donors was 48.5 (Range: 
25-72) years and 57% were women. 57% of the 
donors had a history of smoking. The median 
body mass index of the donors was calculated 
as 26 (Range: 18-33) kg/m2. When ABO blood 
groups were  examined,  it  was  observed   that  
Table 2. Recipient factors that may affect rejection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43% were A, 11% were B and 46% were 0. 
There was no donor from the AB blood group. 
Also, 86% of the donors were Rh +. Two donors 
(7%) had polar arteries. In terms of compliance 
of donors and patients, 11 (39%) patients were 
the same gender with donor, 22 (79%) were 
have the same ABO blood group, and 23 (82%) 
were have similar Rh type with donor. Twenty-
two (79%) of the donors were relatives, and 
there was no relation between the 6 of the 
donors.  
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A total of 8 (28.5%) acute rejections were seen. 
When the patients with and without rejection 
were compared, there was no difference in urine 
output before transplantation, duration of 
dialysis before transplantation, patient age, 
gender, body mass index, smoking history, 
ejection fraction, history of hypertension, blood 
transfusion and previous renal transplantation 
(Table 2). 
The presence of panel reactive antibodies and 
parathyroid hormone levels were different in 
patients with acute graft rejection. Both of the 2 
patients with positive panel reactive antibody 
had rejection, but only 6 of the 26 patients with 
negative PRA had rejection (p= 0.02) (Table 2). 
In addition, patients with acute rejection had 
higher parathyroid hormone levels than patients 
without rejection. The mean parathyroid 
hormone level was 963.2 ± 587 in the rejection 
group and 378 ± 227 in the rejection group (p = 
0.003) (Table 2). 
It was observed that patients with a history of 
DM developed rejection with a frequency of 
37.5% and this rate was observed as 10% in 
patients without a history of DM. The 
difference was close to statistical significance, 
yet, insignificant (p =0.08) (Table 3).  
When the patients with and without rejection 
were examined, it was found that the age, sex, 
smoking status, CMV status, warm ischemia 
time, donor glomerular filtration rate, donor 
body mass index and presence of polar artery 
did not affect the development of rejection 
(Table 3). Similarly, it was found that gender 
accordance between donor and recipient, 
having the same ABO blood type, having the 
same Rh blood type, and the number of 
incompatible HLA mismatch did not affect the 
presence of rejection (Table 3). When the effect 
of the relationship between the donor and the 
recipient on the rejection was investigated, it 
was seen that in all patients having rejection,  
Table 3. The factors related to donor and recipient/ 
donor compatibility that may affect rejection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the transplantation was from the relative donor. 
No rejection was observed in any of the 6 
patients who received transplantation from non-
relative donors. The results were close to 
statistical significance, yet, insignificant (p = 
0.08) (Table 3). 
 
Discussion 
Renal transplantation has recently been 
preferred for better survival and quality of life 
in patients with end-stage renal disease [1]. 
Studies on early graft survival after renal 
transplantation are important in terms of 
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contributing to long-term outcomes. In a study 
with a follow-up of 122 months after renal 
transplantation, a correlation was found 
between proteinuria (calculated with protein 
creatinine ratio) and poor graft function in the 
first 3 months. The advantage of this study is 
long follow-up period and especially values 
higher than 0.5% of protein creatinine ratio 
have been found to be observed more 
frequently in vascular events [31]. No 
correlation was found in our study between 
rejection and micro-albumin/creatinine ratio in 
spot urine at 0, 3 and 6 months. The lack of 
correlation with respect to graft survival may be 
due to our lower follow-up. 
One of the issues that can be important in the 
anamnesis is the history of blood product 
transfusion before transplantation. Erythrocyte 
transfusion may result in HLA antigen 
sensitization. The highest risk for sensitization 
occurred in multipara women, multiple 
transfusions, and failed organ transplants, but 
previous data have shown equal or greater risk 
for men. As a result, an increase in PRA is 
associated with poor graft survival [11, 12]. In 
our study, no correlation was found between the 
recipient's blood product transfusion history 
and the number of incompatible HLAs between 
the recipient and the donor, while rejection 
developed in 2 of the 2 patients with panel 
reactive antibody positivity. The ratio of PRA 
positivity was 25% among patients who 
developed rejection and 0% in patients who did 
not develop rejection. Our findings are 
compatible with the literature. 
Another factor related to the survival of the 
transplanted kidney is the age of the recipient 
and donor. Renal recipients have an increased 
risk of graft failure, especially with age greater 
than 60 years [14]. When kidney donors are 
examined, it is seen that graft failure and long-
term mortality are increased in the recipients of 
older donors compared to younger donor cases. 
However, these recipients appear to be better or 
more accomplished than those of the kidneys of 
donors with standard or extended criteria [15]. 
When we examined our patients with and 
without rejection, it was found that the age of 
the donor did not affect the development of 
rejection. This may be due to younger age of 
our patients and donors. 
Early results up to one year after kidney 
transplantation may also be affected by the 
nutritional status of the recipients. In our study, 
we found significantly higher rates of early 
graft failure in both thinner and overweighed 
recipients. The incidence of early graft loss 
increases in those recipients and may be due to 
the more frequent technical problems of the 
operation in obese patients [16, 17]. In our 
study, we could not show any relationship 
between increase in body mass index and 
rejection rate probably due to no obese patients 
was present in our cohort. 
When we examine the effects of smoking on 
endothelial damage and its effect on delaying or 
even preventing the healing process; previously 
or active smoking is associated with decreased 
patient and graft survival and increased 
rejection rate [18]. It was shown that the 
smoking of the donor and the recipient was not 
significant between the patients with and 
without rejection. This may be due to the short 
follow-up period. 
Although diabetes is a common cause of end-
stage renal disease, new-onset diabetes after 
transplantation can be an important 
complication of renal transplantation [19]. 
New-onset diabetes influences allograft 
survival and has an impact on renal function 
and increased cardiovascular risk, leading to 
patient survival [20-22]. In a prospective study, 
the 12-year graft survival rate was 70% in the 
non-diabetic control group and 48% in those 
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developing new-onset diabetes [32]. In our 
study, diabetes mellitus, which was present 
before renal transplantation, was found to have 
a trend for association with rejection. 
In a study about 13881 primary renal transplant 
recipients, low after dialysis diastolic blood 
pressure and low pre dialysis diastolic blood 
pressure were associated with decreased risk of 
death, whereas high diastolic blood pressure 
after dialysis was associated with increased risk 
of death. Low blood pressure before 
transplantation was also associated with 
decreased risk of graft failure [23]. In our 
patients, it was shown that the factors affecting 
the rejection of the graft kidney did not include 
the pre-transplant hypertension. This may be 
due to the small number of patients. 
Acute rejection of both cellular and humoral 
type may lead to long-term changes due to 
reduced graft survival [25-28]. Acute rejection 
findings of both cellular and humoral types 
were observed in our patients. Humoral 
antibody was positive in 2 of 8 patients with 
acute rejection. 
Compared with patients without acute 
rejection, those with acute rejection at 1 year 
were more frequently observed in patients with 
a greater number of HLA mismatch [29]. In our 
study, no correlation was found between HLA 
compliance and rejection rate. However, we 
found that PRA positivity is correlated with 
acute graft rejection. 
It has been found that decreased early graft 
function after kidney transplantation from live 
donors reduces graft survival without rejection. 
However, its effect on graft survival in the long 
term is not clear. Decreased early graft function 
is defined as delayed or slow graft function. 
Weight gain, pre-transplantation dialysis 
treatment and warm ischemia have been 
identified as risk factors for the emergence of 
decreased early graft function. Decreased early 
graft function also showed negative effects on 
long-term graft survival [30]. In our patients, 
BMI of the recipient, pre-transplantation 
dialysis treatment and duration of warm 
ischemia were not significantly different in 
terms of rejection. 
High serum PTH levels in both pre-
transplantation and post-transplantation were 
associated with decreased graft function. 
Roodnat and colleagues in the study of 407 
renal recipients in terms of total graft survival 
when evaluated in terms of high pre-
transplantation PTH level was found to be a 
linear relationship between graft failures [33]. 
In our study, a positive correlation was found 
with higher level of PTH in the pre-
transplantation period with acute graft 
rejection. 
In conclusion, we found that pre-
transplantation PRA positivity and post-
transplantation parathyroid hormone levels 
increased the probability of rejection. The effect 
of the presence of diabetes mellitus on the 
development of rejection was limited. 
Therefore, we suggest that strictly following-up 
PRA and parathyroid hormone levels in renal 
transplant recipients. 
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